DISPERSYN GERRIT (Chief Development Officer) purchased 6.7% of their position (6K shares) of PHIO PHARMACEUTICALS CORP. on the open market
Open‑market purchase worth $9.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/17/2021ACC: 0001209191-21-051759
Officer· Chief Development Officer
Since Aug 2018
+6K
Net shares
Net buyer
$9.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6K acquired
Non-Derivative Transactions1
Common stock, $0.0001 par value
Direct
Shares
+6K
Price / share
$1.63
Trade value
$9.78K
% of position
6.7%
8/16/2021
89.28K→95.28K
Total
Net shares
+6K
Net value
$9.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 8/16/2021 | P · Purchase | +6K | $1.63 | $9.78K | 6.7% | 89.28K | 95.28K |
| Total | +6K | $9.78K | ||||||
Derivative Transactions0
No derivative transactions reported